全文获取类型
收费全文 | 874篇 |
免费 | 37篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 53篇 |
妇产科学 | 12篇 |
基础医学 | 77篇 |
口腔科学 | 11篇 |
临床医学 | 85篇 |
内科学 | 106篇 |
皮肤病学 | 9篇 |
神经病学 | 81篇 |
特种医学 | 165篇 |
外科学 | 88篇 |
综合类 | 79篇 |
预防医学 | 40篇 |
眼科学 | 31篇 |
药学 | 58篇 |
中国医学 | 1篇 |
肿瘤学 | 35篇 |
出版年
2021年 | 7篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 10篇 |
2017年 | 12篇 |
2016年 | 11篇 |
2015年 | 23篇 |
2014年 | 23篇 |
2013年 | 30篇 |
2012年 | 33篇 |
2011年 | 24篇 |
2010年 | 20篇 |
2009年 | 19篇 |
2008年 | 27篇 |
2007年 | 33篇 |
2006年 | 50篇 |
2005年 | 22篇 |
2004年 | 27篇 |
2003年 | 17篇 |
2002年 | 17篇 |
2001年 | 29篇 |
2000年 | 20篇 |
1999年 | 18篇 |
1998年 | 36篇 |
1997年 | 27篇 |
1996年 | 29篇 |
1995年 | 26篇 |
1994年 | 26篇 |
1993年 | 33篇 |
1992年 | 18篇 |
1991年 | 12篇 |
1990年 | 21篇 |
1989年 | 19篇 |
1988年 | 11篇 |
1987年 | 14篇 |
1986年 | 28篇 |
1985年 | 13篇 |
1984年 | 17篇 |
1983年 | 11篇 |
1982年 | 12篇 |
1981年 | 15篇 |
1980年 | 16篇 |
1979年 | 5篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1974年 | 3篇 |
1971年 | 3篇 |
1970年 | 3篇 |
1966年 | 5篇 |
排序方式: 共有933条查询结果,搜索用时 15 毫秒
151.
Radiographic mottle and patient exposure in mammography 总被引:1,自引:0,他引:1
152.
153.
154.
Vena Tech-LGM filter: long-term results of a prospective study 总被引:12,自引:0,他引:12
Crochet DP; Stora O; Ferry D; Grossetete R; Leurent B; Brunel P; Nguyen JM 《Radiology》1993,188(3):857
155.
156.
157.
158.
Toups MS Greer TL Kurian BT Grannemann BD Carmody TJ Huebinger R Rethorst C Trivedi MH 《Journal of psychiatric research》2011,45(10):1301-1306
Background
Brain Derived Neurotrophic Factor (BDNF) has potential as a biomarker of depression treatment because serum BDNF in depressed human subjects is decreased and normalizes with treatment. The relationship between serum BDNF and exercise treatment of depression is not known. The Treatment with Exercise Augmentation for Depression (TREAD) study examined dosed exercise augmentation treatment of partial responders to antidepressants. Serum BDNF in TREAD subjects was analyzed to understand its relationship with exercise training.Methods
Subjects were randomized to high (16 kcal/kg/week or KKW) or low (4 KKW) energy expenditure exercise over 12 weeks. Actual kcal/week expended and IDS-C scores were collected weekly. One hundred four subjects in TREAD provided baseline blood samples; a subset of 70 subjects also provided week 12 samples. Serum BDNF was determined using ELISA. Correlations were examined between change in BDNF and 1) mean kcal/week expended, and 2) change in IDS-C score. Mixed-effects ANOVA examined the effect of baseline BDNF on outcome.Results
Resting serum BDNF was stable and did not correlate with energy expenditure (p = 0.15) or IDS-C improvement (p = 0.89). Subjects entering the study with higher BDNF improved more rapidly on the IDS-C (p = 0.003).Limitations
Serum may not be the most sensitive blood fraction in which to measure BDNF change. Pre-treatment with medication may mask exercise effect on BDNF.Conclusions
These results suggest that change in serum BDNF does not reflect efficacy of exercise augmentation treatment of MDD. Instead BDNF may function as an augmentation moderator. Pre-treatments that raise BDNF may improve the efficacy of exercise treatment of MDD. 相似文献159.
David Carmody Aoife Doyle Richard GR Firth Maria M Byrne Sean Daly Fionnuala Mc Auliffe Micheal Foley Samuel Coulter‐Smith Kinsley Brendan T 《Pediatric diabetes》2010,11(2):111-115
Carmody D, Doyle A, Firth RGR, Byrne MM, Daly S, Mc Auliffe F, Foley M, Coulter‐Smith S, Kinsley BT. Teenage pregnancy in type 1 diabetes mellitus Younger maternal age at delivery has been linked to adverse reproductive outcomes. Pregnancy complicated by type 1 diabetes mellitus (T1DM) is also associated with adverse pregnancy outcomes. Optimising diabetic glycaemic control prior to pregnancy is known to reduce the rate of congenital abnormalities and improve pregnancy outcomes. Teenage pregnancies are not usually planned and little data exist on teenage pregnancy complicated by T1DM. We sought to identify the glycemic control achieved in teenage pregnancy with T1DM and to clarify if there is an associated increase in adverse pregnancy outcomes compared to those seen in older women with T1DM. We compared outcomes in 18 teenagers (TG) with 582 older women with T1DM (CON) from 1995–2007. TG booked to the combined diabetes‐obstetrical service at a median gestational age of 11 weeks (range 6–22) compared to 7 weeks in CON (range 4–40, p < 0.02). Glycaemic was worse in TG compared to CON at 13, 26 and 35 weeks gestation, despite higher insulin doses. First trimester miscarriage rate did not differ between groups. Major congenital anomaly rate was 6.2% (1/16) compared to 3.2% in CON. This preliminary study has demonstrated that pregnant teenage women with T1DM book later to specialised care and have worse glycaemic control in pregnancy compared to older women with T1DM. This group also appear to be more insulin resistant than older women in early pregnancy. Our data would suggest that teenagers with type 1 diabetes mellitus may constitute a high‐risk group for adverse pregnancy outcomes. 相似文献
160.
E. Sherwood Brown Thomas J. Carmody Joy M. Schmitz Raul Caetano Bryon Adinoff Alan C. Swann A. John Rush 《Alcoholism, clinical and experimental research》2009,33(11):1863-1869
Background: Alcohol dependence is extremely common in patients with bipolar disorder and is associated with unfavorable outcomes including treatment nonadherence, violence, increased hospitalization, and decreased quality of life. While naltrexone is a standard treatment for alcohol dependence, no controlled trials have examined its use in patients with co-morbid bipolar disorder and alcohol dependence. In this pilot study, the efficacy of naltrexone in reducing alcohol use and on mood symptoms was assessed in bipolar disorder and alcohol dependence.
Methods: Fifty adult outpatients with bipolar I or II disorders and current alcohol dependence with active alcohol use were randomized to 12 weeks of naltrexone (50 mg/d) add-on therapy or placebo. Both groups received manual-driven cognitive behavioral therapy designed for patients with bipolar disorder and substance-use disorders. Drinking days and heavy drinking days, alcohol craving, liver enzymes, and manic and depressed mood symptoms were assessed.
Results: The 2 groups were similar in baseline and demographic characteristics. Naltrexone showed trends ( p < 0.10) toward a greater decrease in drinking days (binary outcome), alcohol craving, and some liver enzyme levels than placebo. Side effects were similar in the 2 groups. Response to naltrexone was significantly related to medication adherence.
Conclusions: Results suggest the potential value and acceptable tolerability of naltrexone for alcohol dependence in bipolar disorder patients. A larger trial is needed to establish efficacy. 相似文献
Methods: Fifty adult outpatients with bipolar I or II disorders and current alcohol dependence with active alcohol use were randomized to 12 weeks of naltrexone (50 mg/d) add-on therapy or placebo. Both groups received manual-driven cognitive behavioral therapy designed for patients with bipolar disorder and substance-use disorders. Drinking days and heavy drinking days, alcohol craving, liver enzymes, and manic and depressed mood symptoms were assessed.
Results: The 2 groups were similar in baseline and demographic characteristics. Naltrexone showed trends ( p < 0.10) toward a greater decrease in drinking days (binary outcome), alcohol craving, and some liver enzyme levels than placebo. Side effects were similar in the 2 groups. Response to naltrexone was significantly related to medication adherence.
Conclusions: Results suggest the potential value and acceptable tolerability of naltrexone for alcohol dependence in bipolar disorder patients. A larger trial is needed to establish efficacy. 相似文献